{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T12:51:46Z","timestamp":1779367906209,"version":"3.53.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"DOI":"10.1186\/s12884-026-08758-2","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T06:53:59Z","timestamp":1770188039000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The association of first and second-trimester serum biomarkers with adverse perinatal outcomes in late-preterm and term deliveries: a retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2339-1609","authenticated-orcid":false,"given":"\u015eebnem","family":"Karag\u00fcn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2985-0212","authenticated-orcid":false,"given":"Ahmet Zeki","family":"Nessar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6478-813X","authenticated-orcid":false,"given":"Hamza","family":"Y\u0131ld\u0131z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7162-4644","authenticated-orcid":false,"given":"Yusuf","family":"Dal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1595-2621","authenticated-orcid":false,"given":"Sefanur Gamze","family":"Karaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2887-9649","authenticated-orcid":false,"given":"Ayhan","family":"Co\u015fkun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"issue":"3","key":"8758_CR1","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/1471-0528.17983","volume":"132","author":"JCA van Eekhout","year":"2025","unstructured":"van Eekhout JCA, Becking EC, Scheffer PG, Koutsoliakos I, Bax CJ, Henneman L, et al. First-Trimester prediction models based on maternal characteristics for adverse pregnancy outcomes: A systematic review and Meta-Analysis. BJOG. 2025;132(3):243\u201365.","journal-title":"BJOG"},{"issue":"1","key":"8758_CR2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ajog.2015.06.013","volume":"214","author":"CE Kleinrouweler","year":"2016","unstructured":"Kleinrouweler CE, Cheong-See FM, Collins GS, Kwee A, Thangaratinam S, Khan KS, et al. Prognostic models in obstetrics: available, but Far from applicable. Am J Obstet Gynecol. 2016;214(1):79\u2013e9036.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"8758_CR3","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/1471-0528.15516","volume":"126","author":"L Meertens","year":"2019","unstructured":"Meertens L, Smits L, van Kuijk S, Aardenburg R, van Dooren I, Langenveld J, et al. External validation and clinical usefulness of first-trimester prediction models for small- and large-for-gestational-age infants: a prospective cohort study. BJOG. 2019;126(4):472\u201384.","journal-title":"BJOG"},{"issue":"2","key":"8758_CR4","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/S1701-2163(16)35157-X","volume":"34","author":"D Hui","year":"2012","unstructured":"Hui D, Okun N, Murphy K, Kingdom J, Uleryk E, Shah PS. Combinations of maternal serum markers to predict preeclampsia, small for gestational age, and stillbirth: a systematic review. J Obstet Gynaecol Can. 2012;34(2):142\u201353.","journal-title":"J Obstet Gynaecol Can"},{"key":"8758_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2393-8-33","volume":"8","author":"RK Morris","year":"2008","unstructured":"Morris RK, Cnossen JS, Langejans M, Robson SC, Kleijnen J, Ter Riet G, et al. Serum screening with down\u2019s syndrome markers to predict pre-eclampsia and small for gestational age: systematic review and meta-analysis. BMC Pregnancy Childbirth. 2008;8:33.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"Suppl 1","key":"8758_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s13224-015-0826-2","volume":"66","author":"K Godbole","year":"2016","unstructured":"Godbole K, Kulkarni A, Kanade A, Kulkarni S, Godbole G, Wakankar A. Maternal serum aneuploidy screen and adverse pregnancy outcomes. J Obstet Gynaecol India. 2016;66(Suppl 1):141\u20138.","journal-title":"J Obstet Gynaecol India"},{"issue":"1","key":"8758_CR7","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.fertnstert.2007.02.024","volume":"89","author":"S Canini","year":"2008","unstructured":"Canini S, Prefumo F, Pastorino D, Crocetti L, Afflitto CG, Venturini PL, et al. Association between birth weight and first-trimester free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A. Fertil Steril. 2008;89(1):174\u20138.","journal-title":"Fertil Steril"},{"issue":"23","key":"8758_CR8","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1080\/14767058.2019.1698031","volume":"34","author":"I Suciu","year":"2021","unstructured":"Suciu I, Galeva S, Abdel Azim S, Pop L, Toader O. First-trimester screening-biomarkers and cell-free DNA. J Matern Fetal Neonatal Med. 2021;34(23):3983\u20139.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"5","key":"8758_CR9","doi-asserted-by":"publisher","first-page":"e0298643","DOI":"10.1371\/journal.pone.0298643","volume":"19","author":"E Sebire","year":"2024","unstructured":"Sebire E, Rodrigo CH, Bhattacharya S, Black M, Wood R, Vieira R. The implementation and impact of non-invasive prenatal testing (NIPT) for down\u2019s syndrome into antenatal screening programmes: A systematic review and meta-analysis. PLoS ONE. 2024;19(5):e0298643.","journal-title":"PLoS ONE"},{"issue":"1","key":"8758_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/cge.13155","volume":"94","author":"L Nshimyumukiza","year":"2018","unstructured":"Nshimyumukiza L, Menon S, Hina H, Rousseau F, Reinharz D. Cell-free DNA noninvasive prenatal screening for aneuploidy versus conventional screening: A systematic review of economic evaluations. Clin Genet. 2018;94(1):3\u201321.","journal-title":"Clin Genet"},{"issue":"4","key":"8758_CR11","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1515\/jpm-2022-0241","volume":"51","author":"T Kantomaa","year":"2023","unstructured":"Kantomaa T, V\u00e4\u00e4r\u00e4sm\u00e4ki M, Gissler M, Sairanen M, Nevalainen J. First trimester low maternal serum pregnancy associated plasma protein-A (PAPP-A) as a screening method for adverse pregnancy outcomes. J Perinat Med. 2023;51(4):500\u20139.","journal-title":"J Perinat Med"},{"key":"8758_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ejogrb.2023.01.016","volume":"282","author":"P Kosinski","year":"2023","unstructured":"Kosinski P, Fr\u00fchauf A, Lipa M, Szczepkowska A, Luterek K, Falis M, et al. Clinical consequences of maternal serum PAPP-A and free beta hCG levels above 2.0 multiple of median in the first trimester screening. Eur J Obstet Gynecol Reprod Biol. 2023;282:101\u20134.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"8758_CR13","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1016\/j.ajog.2004.06.052","volume":"191","author":"L Dugoff","year":"2004","unstructured":"Dugoff L, Hobbins JC, Malone FD, Porter TF, Luthy D, Comstock CH, et al. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol. 2004;191(4):1446\u201351.","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"8758_CR14","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/pd.4407","volume":"34","author":"TL Halscott","year":"2014","unstructured":"Halscott TL, Ramsey PS, Reddy UM. First trimester screening cannot predict adverse outcomes yet. Prenat Diagn. 2014;34(7):668\u201376.","journal-title":"Prenat Diagn"},{"issue":"4","key":"8758_CR15","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1097\/AOG.0000000000004084","volume":"136","author":"Screening for Fetal Chromosomal Abnormalities","year":"2020","unstructured":"Screening for Fetal Chromosomal Abnormalities. ACOG practice Bulletin, number 226. Obstet Gynecol. 2020;136(4):e48\u201369.","journal-title":"Obstet Gynecol"},{"issue":"3","key":"8758_CR16","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.tjog.2022.02.043","volume":"61","author":"S Genc","year":"2022","unstructured":"Genc S, Ozer H, Emeklioglu CN, Cingillioglu B, Sahin O, Akturk E, et al. Relationship between extreme values of first trimester maternal pregnancy associated plasma Protein-A, free-\u03b2-human chorionic gonadotropin, nuchal translucency and adverse pregnancy outcomes. Taiwan J Obstet Gynecol. 2022;61(3):433\u201340.","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"9","key":"8758_CR17","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/pd.407","volume":"22","author":"Y Yaron","year":"2002","unstructured":"Yaron Y, Heifetz S, Ochshorn Y, Lehavi O, Orr-Urtreger A. Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome. Prenat Diagn. 2002;22(9):778\u201382.","journal-title":"Prenat Diagn"},{"issue":"1","key":"8758_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/uog.26106","volume":"61","author":"CM Bilardo","year":"2023","unstructured":"Bilardo CM, Chaoui R, Hyett JA, Kagan KO, Karim JN, Papageorghiou AT, et al. ISUOG practice guidelines (updated): performance of 11-14-week ultrasound scan. Ultrasound Obstet Gynecol. 2023;61(1):127\u201343.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"8758_CR19","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/uog.24888","volume":"59","author":"LJ Salomon","year":"2022","unstructured":"Salomon LJ, Alfirevic Z, Berghella V, Bilardo CM, Chalouhi GE, Da Silva Costa F, et al. ISUOG practice guidelines (updated): performance of the routine mid-trimester fetal ultrasound scan. Ultrasound Obstet Gynecol. 2022;59(6):840\u201356.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"8758_CR20","doi-asserted-by":"publisher","unstructured":"Executive summary: Neonatal encephalopathy and neurologic outcome, second edition. Report of the American College of Obstetricians and Gynecologists' Task Force on Neonatal Encephalopathy. Obstet Gynecol. 2014 Apr;123(4):896-901.https:\/\/doi.org\/10.1097\/01.AOG.0000445580.65983.d2.","DOI":"10.1097\/01.AOG.0000445580.65983.d2"},{"issue":"4","key":"8758_CR21","doi-asserted-by":"publisher","first-page":"B2","DOI":"10.1016\/j.ajog.2020.05.010","volume":"223","author":"JG Martins","year":"2020","unstructured":"Martins JG, Biggio JR, Abuhamad A. Society for Maternal-Fetal medicine consult series #52: diagnosis and management of fetal growth restriction: (Replaces clinical guideline number 3, April 2012). Am J Obstet Gynecol. 2020;223(4):B2\u201317.","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"8758_CR22","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.jogc.2022.08.014","volume":"44","author":"S Ronzoni","year":"2022","unstructured":"Ronzoni S, Boucoiran I, Yudin MH, Coolen J, Pylypjuk C, Melamed N, et al. Guideline 430: diagnosis and management of preterm prelabour rupture of membranes. J Obstet Gynaecol Can. 2022;44(11):1193\u2013e2081.","journal-title":"J Obstet Gynaecol Can"},{"issue":"Suppl 1","key":"8758_CR23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s13224-021-01508-8","volume":"72","author":"Z Alizadeh-Dibazari","year":"2022","unstructured":"Alizadeh-Dibazari Z, Alizadeh-Ghodsi Z, Fathnezhad-Kazemi A. Association between serum markers used in the routine prenatal screening with pregnancy outcomes: A cohort study. J Obstet Gynaecol India. 2022;72(Suppl 1):6\u201318.","journal-title":"J Obstet Gynaecol India"},{"issue":"6","key":"8758_CR24","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s00404-015-3947-z","volume":"293","author":"P Cignini","year":"2016","unstructured":"Cignini P, Maggio Savasta L, Gulino FA, Vitale SG, Mangiafico L, Mesoraca A, et al. Predictive value of pregnancy-associated plasma protein-A (PAPP-A) and free beta-hCG on fetal growth restriction: results of a prospective study. Arch Gynecol Obstet. 2016;293(6):1227\u201333.","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"8758_CR25","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.ajog.2004.05.068","volume":"191","author":"D Krantz","year":"2004","unstructured":"Krantz D, Goetzl L, Simpson JL, Thom E, Zachary J, Hallahan TW, et al. Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Am J Obstet Gynecol. 2004;191(4):1452\u20138.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"8758_CR26","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s13224-023-01919-9","volume":"74","author":"RS Sruthi","year":"2024","unstructured":"Sruthi RS, Sarita P, Marandi S, Nayak S, Pati T. Early trimester maternal serum \u03b2-hCG and PAPP-A levels as predictor of hypertensive disorders of pregnancy. J Obstet Gynaecol India. 2024;74(3):231\u20135.","journal-title":"J Obstet Gynaecol India"},{"key":"8758_CR27","doi-asserted-by":"publisher","unstructured":"Swiercz G, Zmelonek-Znamirowska A, Szwabowicz K, Armanska J, Detka K, Mlodawska M, et al. Navigating Uncertain Waters: First-Trimester Screening's Role in Identifying Neonatal Complications. J Clin Med. 2024 Mar 29;13(7):1982. https:\/\/doi.org\/10.3390\/jcm13071982.","DOI":"10.3390\/jcm13071982"},{"issue":"2","key":"8758_CR28","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3109\/01443615.2015.1036400","volume":"36","author":"P Sirikunalai","year":"2016","unstructured":"Sirikunalai P, Wanapirak C, Sirichotiyakul S, Tongprasert F, Srisupundit K, Luewan S, et al. Associations between maternal serum free beta human chorionic gonadotropin (\u03b2-hCG) levels and adverse pregnancy outcomes. J Obstet Gynaecol. 2016;36(2):178\u201382.","journal-title":"J Obstet Gynaecol"},{"issue":"10","key":"8758_CR29","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/pd.4174","volume":"33","author":"AR Zizzo","year":"2013","unstructured":"Zizzo AR, Kirkegaard I, Henriksen TB, Ulbjerg N. Pregnancy-associated plasma protein A levels and neonatal complications in post-date pregnancies. Prenat Diagn. 2013;33(10):965\u201372.","journal-title":"Prenat Diagn"},{"issue":"12","key":"8758_CR30","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1002\/pd.2858","volume":"31","author":"I Kirkegaard","year":"2011","unstructured":"Kirkegaard I, Uldbjerg N, Henriksen TB. PAPP-A and free \u03b2-hCG in relation to admission to neonatal intensive care unit and neonatal disease. Prenat Diagn. 2011;31(12):1169\u201375.","journal-title":"Prenat Diagn"},{"issue":"6","key":"8758_CR31","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/1471-0528.17691","volume":"131","author":"U Sovio","year":"2024","unstructured":"Sovio U, Gaccioli F, Cook E, Charnock-Jones DS, Smith GCS. Association between adverse pregnancy outcome and placental biomarkers in the first trimester: A prospective cohort study. BJOG. 2024;131(6):823\u201331.","journal-title":"BJOG"},{"issue":"2","key":"8758_CR32","doi-asserted-by":"publisher","first-page":"102732","DOI":"10.1016\/j.jogc.2024.102732","volume":"47","author":"ML C\u00f4t\u00e9","year":"2025","unstructured":"C\u00f4t\u00e9 ML, Gigu\u00e8re Y, Forest JC, Audibert F, Johnson JA, Okun N, et al. First-Trimester PlGF and PAPP-A and the risk of Placenta-Mediated complications: PREDICTION prospective study. J Obstet Gynaecol Can. 2025;47(2):102732.","journal-title":"J Obstet Gynaecol Can"},{"issue":"10","key":"8758_CR33","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/S1701-2163(16)32973-5","volume":"30","author":"A Gagnon","year":"2008","unstructured":"Gagnon A, Wilson RD. Obstetrical complications associated with abnormal maternal serum markers analytes. J Obstet Gynaecol Can. 2008;30(10):918\u201332.","journal-title":"J Obstet Gynaecol Can"},{"issue":"7","key":"8758_CR34","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1515\/jpm-2016-0101","volume":"45","author":"K Bartkute","year":"2017","unstructured":"Bartkute K, Balsyte D, Wisser J, Kurmanavicius J. Pregnancy outcomes regarding maternal serum AFP value in second trimester screening. J Perinat Med. 2017;45(7):817\u201320.","journal-title":"J Perinat Med"},{"issue":"1","key":"8758_CR35","doi-asserted-by":"publisher","first-page":"2175848","DOI":"10.1080\/10641963.2023.2175848","volume":"45","author":"X Dai","year":"2023","unstructured":"Dai X, Zhang H, Wu B, Ning W, Chen Y, Chen Y. Correlation between elevated maternal serum alpha-fetoprotein and ischemic placental disease: a retrospective cohort study. Clin Exp Hypertens. 2023;45(1):2175848.","journal-title":"Clin Exp Hypertens"},{"issue":"3","key":"8758_CR36","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/pd.5001","volume":"37","author":"RK Morris","year":"2017","unstructured":"Morris RK, Bilagi A, Devani P, Kilby MD. Association of serum PAPP-A levels in first trimester with small for gestational age and adverse pregnancy outcomes: systematic review and meta-analysis. Prenat Diagn. 2017;37(3):253\u201365.","journal-title":"Prenat Diagn"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-026-08758-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-08758-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-08758-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T23:05:09Z","timestamp":1771974309000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12884-026-08758-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8758"],"URL":"https:\/\/doi.org\/10.1186\/s12884-026-08758-2","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"assertion":[{"value":"20 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki and relevant national regulations, including the Regulation on Clinical Trials of New Medicinal Products for Human Use (Official Gazette dated 27.05.2023, No. 32203). Ethical approval was obtained from the Institutional Review Board (IRB) of Mersin University Clinical Research Ethics Committee (Decision No: 2024\/346). The study was designed as a retrospective cohort study using routinely collected clinical and laboratory data. All data were fully anonymized prior to analysis, and no identifying personal information was accessed or used. In accordance with the above regulation and national legislation, the requirement for obtaining informed consent was reviewed by the Institutional Review Board and deemed unnecessary, given the retrospective nature of the study and the use of anonymized data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"200"}}